Speaker

Rui Santos Ivo
Vice President
INFARMED
Rui Santos Ivo is currently President of INFARMED – National Authority of Medicines and Health Products, I.P., since June 2019. Member of the Management Board of the EMA, since March 2016. Member of the Executive Board of EUnetHTA - the European Network for Health Technology Assessment, since June 2016. Vice-chair of the Valletta Permanent Technical Committee/Valletta Declaration, since July 2017.

He is also an Invited Assistant Professor of Medicines Regulation, at the Faculty of Pharmacy of the University of Lisbon, where he is a member of the School Council.

He is an external elected member of the General Council of the University of Coimbra, since 2017.

Previously he was President (2014/2016) and Vice-President (2011/2014) of the Central Administration of the Health System (ACSS,IP) at the Ministry of Health, in Portugal. He was Coordinator of the Hospital Reform Project Team (2012/2015) and chaired the Governance College for the Public Health Subsystems (2015/2016).

R. Santos Ivo initiated his professional career as a hospital pharmacist at Hospital de Egas Moniz, in Lisbon. In 1993 he joined INFARMED, where he held various responsibilities, namely vice-president (1994-2000; 2016-2019) and President (2002-2005).

In 2000 and 2002 he worked as Administrator at the Directorate of the European Medicines Agency (EMA), in London, and in 2006 and 2008 he worked for the European Commission as Administrator at the Pharmaceuticals Unit, Directorate General for Enterprise and Industry, in Brussels.  

He was a member of the Management Board of the EMA (2002/2005) and the first Chairman of the European Union Heads of Medicines Agencies Management Group (2004-2005).
In 2008-2011 he was Executive Director of the Portuguese Association of the Pharmaceutical Industry (APIFARMA).

R. Santos Ivo graduated in Pharmaceutical Sciences by the University of Lisbon in 1987. Specialist in Hospital Pharmacy (1992) and Pharmaceutical Regulation by the Portuguese Pharmaceutical Society (1997). Post graduate education on Health Law and Pharmaceutical Legislation (University of Lisbon Faculty of Law and National School of Public Health), Pharmaceutical Medicine (University of Basel), Regulation (London School of Economics and Political Science) and Health Management (Portuguese Catholic University (2000) and AESE (2015)).

Almofariz Prize, Personality of the Year in the Pharmaceutical Sector (2004), European Correspondent Member, Académie Nationale de Pharmacie, France (2014) and Medal (gold) for distinguished Services, Ministry of Health (2015).